pyrazolanthrone has been researched along with Cognitive Decline in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ke, Y; Liu, Y; Qi, R; Ren, Y; Wang, W; Wang, Y; Yan, Z | 1 |
| Feng, S; He, J; Li, Q; Ling, H; Song, Z; Wang, Z; Yan, C; Yang, S | 1 |
| Jing, GC; Liu, D; Liu, YQ; Zhang, MR | 1 |
3 other study(ies) available for pyrazolanthrone and Cognitive Decline
| Article | Year |
|---|---|
Electroacupuncture inhibits hippocampal neuronal apoptosis and improves cognitive dysfunction in mice with vascular dementia via the JNK signaling pathway.
Topics: Apoptosis; Cognitive Dysfunction; Dementia, Vascular; Electroacupuncture; Hippocampus; Humans; MAP Kinase Signaling System; RNA, Messenger | 2023 |
Dihydromyricetin alleviates hippocampal ferroptosis in type 2 diabetic cognitive impairment rats via inhibiting the JNK-inflammatory factor pathway.
Topics: Animals; Cognitive Dysfunction; Diabetes Mellitus, Type 2; Ferroptosis; Hippocampus; Iron; Rats | 2023 |
Nao-Fu-Cong ameliorates diabetic cognitive dysfunction by inhibition of JNK/CHOP/Bcl2-mediated apoptosis in vivo and in vitro.
Topics: Acetylcysteine; Animals; Anthracenes; Apoptosis; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Hippocampus; Male; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Neurons; Neuroprotective Agents; Proto-Oncogene Proteins c-bcl-2; Random Allocation; Rats; Transcription Factor CHOP | 2020 |